Photoactivation of endogenous porphyrins for treatment of psoriasis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6269818
SERIAL NO

09084865

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

In one aspect, the invention provides a diagnostic method for identifying psoriatic plaques in which Porphyrins, particularly protoporphyrin IX, are elevated as compared to normal skin and skin of patients with other dermatological diseases, including other forms of psoriatic plaque. Psoriatic plaques with elevated porphyrin levels may be detected by fluorescence and spectral analysis. Endogenous porphyrins in psoriatic plaques may be activated with visible light to treat psoriatic plaques having elevated porphyrin concentrations. Skin conditions may be optimized to increase the endogenous concentration of porphyrins in psoriatic plaques. A topical formulation may be applied to psoriatic plaques to optimize skin conditions such as pH, iron concentration, temperature, hydration, calcium concentration, oxygenation, electrical conductivity and estrogen concentration to increase the concentration of endogenous porphyrins.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BRITISH COLUMBIA UNIVERSITY OF THE A NONPROFIT ORGANIZATION2194 HEALTH SCIENCES MALL VANCOUVER BRITISH COLUMBIA V6T 1

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bissonnette, Robert Vancouver, CA 2 35
Lui, Harvey Vancouver, CA 13 710
Macaulay, Calum Vancouver, CA 11 1459
McLean, David I Vancouver, CA 10 620
Zeng, Haishan Delta, CA 42 2654

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation